Champions Oncology (CSBR) Receivables - Other (2016 - 2026)
Champions Oncology (CSBR) has 15 years of Receivables - Other data on record, last reported at $7.2 million in Q4 2025.
- For Q4 2025, Receivables - Other rose 8.09% year-over-year to $7.2 million; the TTM value through Oct 2025 reached $7.2 million, up 8.09%, while the annual FY2025 figure was $5.4 million, 9.14% down from the prior year.
- Receivables - Other reached $7.2 million in Q4 2025 per CSBR's latest filing, up from $5.3 million in the prior quarter.
- Across five years, Receivables - Other topped out at $7.2 million in Q4 2025 and bottomed at $3.0 million in Q2 2021.
- Average Receivables - Other over 5 years is $4.7 million, with a median of $4.3 million recorded in 2022.
- Peak YoY movement for Receivables - Other: surged 89.45% in 2021, then fell 10.7% in 2023.
- A 5-year view of Receivables - Other shows it stood at $4.0 million in 2021, then increased by 8.14% to $4.3 million in 2022, then fell by 7.28% to $4.0 million in 2023, then surged by 65.77% to $6.6 million in 2024, then grew by 8.09% to $7.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Receivables - Other were $7.2 million in Q4 2025, $5.3 million in Q3 2025, and $5.4 million in Q2 2025.